GlassScriptPhysician profile
Ayman Abunimer
NPI 1861951733
$3,837.40
in general payments reported to CMS, 2019-2025
10 companies · $3,267 in 2025
The $3,267 reported for 2025 was more than what 81% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $279 · 2024: $291 · 2025: $3,267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,796 · Travel and Lodging: $1,763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,796.09 |
| Travel and Lodging | $1,762.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,379.44 | 2025 | Ruby Coil, Indigo System, Penumbra System |
| Boston Scientific Corporation | $341.04 | 2025 | Obsidio, Cryoablation Needles |
| Terumo Medical Corporation | $335.61 | 2024-2025 | Azur Cx Detachable, Angio-Seal |
| Inari Medical, INC. | $293.08 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Becton, Dickinson and Company | $134.49 | 2025 | Lutonix Drug Coated Balloon, Trek |
| Genentech USA, INC. | $125.00 | 2022 | |
| Trisalus Life Sciences, INC. | $82.33 | 2025 | Trinav Infusion System |
| Medtronic, INC. | $71.33 | 2025 | Emprint |
| Baylis Medical Technologies INC. | $61.13 | 2025 | |
| Argon Medical Devices, INC. | $13.95 | 2025 | Clot Management |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayman Abunimer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.